baber/WOPTO huggingface dataset:
Patent MD-20070214-A (MD)
Title: Process for producing wine and wine obtained by said process
Inventor: VILLA ADALBERTO
IPC: A23L27/00
Filed: 2007-07-26
Abstract: The invention refers to the wine industry, namely to a process for producing wine and to a wine obtained by said process. The process, according to the invention, includes preparation of the must, clarification thereof, successive administration into the clarified must of at least one tannin and one lyzozyme, as well as the alcoholic fermentation. Due to the utilization of tannin and lyzozime it is excluded the stage of wine traditional sulphitation. The wine obtained by said process does not contain added sulphites and is characterized by chemical and microbiological stability.
Patent MX-159520-A (MX)
Inventor: ITO ELICHI
IPC: F16C11/06
Filed: 1984-07-19
Abstract: The subject of the invention is a ball joint for motor vehicles comprising a bearing insert (4) located between a joint housing (1) and a ball head (3). The bearing insert is provided with meridionally extending slots (9) arranged in a half-portion gripping of the ball head over the equator. A clamping ring (5) located in the housing grips the tongues (10) of this bearing insert (4). To improve the elasticity of the bearing parts while retaining a good distribution of lubricant, the clamping ring (5) is provided with circumferential grooves (13) on its inner surface and with openings (15) in the outer end surface (14).
Patent MX-206517-A (MX)
Title: Procedimiento para preparar un producto leguminosodeshidratado.
Inventor: HUFFMAN SAMUEL J
IPC: A23L11/00
Filed: 1985-09-04
Abstract: Legumbres, tales como judías que son hidratadas y sometidas a cocción para formar una masa antes de conformar la mezcla resultante en configuraciones adecuadas para la deshidratación hasta un contenido en unidad estable en almacenamiento. El producto de judías deshidratado tiene una densidad aparente superior a 0,28 g/cc aproximadamente y a una relación de rehidratación del orden de i,75 a 3,75:1 y es capaz de reconstituirse de un modo sustancialmente uniforme sin que sea necesario agitación física. El producto hidratado es particularmente adecuado para la preparación de 4 judías refritas.
Patent NZ-220967-A (NZ)
Title: 4-nitrogen substituted isoquinolin-3-ol derivatives and pharmaceutical compositions
Inventor: KANOJIA RAMESH M
IPC: C07D413/12
Filed: 1987-07-06
Abstract: Substituted 3-isoquinolinol compounds of the general formula <CHEM> that exhibit cardiotonic and/or phosphodiesterase fraction III inhibiting properties and/or renal vasodilating are pharmacologically active in the treatment of cardiac conditions. Methods for synthesizing and using those compounds are described.
Patent NZ-225566-A (NZ)
Title: Consumable lance having improved wear resistance
Inventor: HAND E L
IPC: C21C5/48
Filed: 1988-07-26
Abstract: A consumable lance for introducing oxygen into molten metal. The lance is designed so that tubular oxygen passageways melt at a relatively low temperature thereby exposing refractory passageways and significantly improving the wear resistance of the lance.
Patent NZ-227200-A (NZ)
Title: Effervescent denture-cleaning tablet
Inventor: YOUNG KENNETH
IPC: A61K8/22
Filed: 1988-12-05
Abstract: Denture cleansing tablet comprising an inorganic persalt bleaching agent, an organic peroxyacid bleach precursor and a solid base material which in the presence of water releases carbon dioxide with effervescence. The composition provides more rapid and efficaceous denture cleansing performance and anti-bacterial activity.
Patent NZ-235888-A (NZ)
Title: Contact lens; iris section has intermittent, coloured pattern of two shades and jagged border therebetween
Inventor: JAHNKE RICHARD L
IPC: G02C7/02
Filed: 1990-10-30
Abstract: A colored contact lens having a very natural appearance is disclosed. The inventive lens has a non-opaque pupil section and iris section that is at least partially opaque and comprised of two portions. A first portion, generally located on the outside of the iris section, has a first shade. A second portion, generally located on the inside of the iris section has a second shade. A jagged border separates the two portions. A third iris section and second jagged border are also disclosed. In some embodiments portions of the iris section may be non-opaque.
Patent NZ-241362-A (NZ)
Title: Nanoparticles of crystalline drugs having a surface modifier adsorbed thereon giving a particle size of less than 400nm; pharmaceutical compositions and preparatory processes
Inventor: LIVERSIDGE GARY G
IPC: A61K9/14
Filed: 1992-01-22
Abstract: Dispersible particles consisting essentially of a crystalline drug substance having a surface modifier adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than about 400 nm, methods for the preparation of such particles and dispersions containing the particles. Pharmaceutical compositions containing the particles exhibit unexpected bioavailability and are useful in methods of treating mammals.
Patent NZ-248574-A (NZ)
Title: Differential release tablet formulation containing naproxen prepared from a mixture of immediate-release granulate, a controlled release-granulate in admixture with retarding agents and a disintegrating agent
Inventor: MARCHI EGIDIO
IPC: A61K9/22
Filed: 1993-09-02
Abstract: Programmed release tablets, to be administered by oral route, containing from 500 to 1,200 mg of naproxen, made by mixtures of an immediate release granulate dry compacted containing from 5% to 28% of naproxen, of a controlled release granulate dry compacted containing from 72% to 95% of naproxen and of a disintegrating agent.   A portion of naproxen is released in a short time, so that the drug can quickly develop its therapeutic action reaching the necessary hematic levels, while the remaining portion is released in a longer interval of time, so as to allow the therapeutic coverage till the subsequent administration. The therapeutic coverage is effective for a period of 24 hours; thus the tablets object of the present invention are suitable for a once a day administration.
Patent NZ-258618-A (NZ)
Title: Humanised antibodies directed against a33 antigen
Inventor: KING DAVID JOHN
IPC: C07K19/00
Filed: 1993-12-10
Abstract: A33 antigen binding proteins are described for use in the diagnosis or treatment of colorectal tumours and metastases arising therefore. The binding protein may be a humanised A33 antibody, including complete antibody molecules, fragments thereof, and, especially, multivalent monospecific proteins comprising two, three, four or more antibodies or fragments thereof bound to each other by a cross-linking agent. For diagnosis or therapy the humanised A33 antibody may be linked to a reporter or effector molecule. <IMAGE>
Patent NZ-273932-A (NZ)
Title: Stereoselective reduction of 3-(1-carboxycyclopentyl)-2-methoxyethoxymethylpropenoic acid and the 4-benzyloxy-carbonylcyclohexylamide in the presence of a chiral rhodium or ruthenium biphosphine catalyst
Inventor: CHALLENGER STEPHEN DR
IPC: C07C69/708
Filed: 1994-09-09
Abstract: Compounds of formula (I) or (Ia): <CHEM> where R is 5-indanyl or a carboxylic acid protecting group, or an amine salt thereof, are prepared by hydrogenating an (E)-allylic ether of formula (II) or (IIa): <CHEM> in the presence of a stereoselective rhodium or ruthenium biphosphine catalyst and a protic solvent.
Patent NZ-290470-A (NZ)
Title: Electrically generated gas moves diaphragm to orally administer medicament
Inventor: GROSS JOSEPH
IPC: A61K9/00
Filed: 1995-08-04
Abstract: PCT No. PCT/IE95/00039 Sec. 371 Date Sep. 29, 1997 Sec. 102(e) Date Sep. 29, 1997 PCT Filed Aug. 4, 1995 PCT Pub. No. WO96/04953 PCT Pub. Date Feb. 22, 1996Oral drug delivery device having a housing with walls of water permeable material and having at least two chambers separated by a displaceable membrane. The first chamber receives drug and has an orifice through which the drug is expelled under pressure. The second chamber contains at least one of two spaced apart electrodes forming part of an electric circuit which is closed by the ingress of an aqueous ionic solution into the second chamber. When current flows through the circuit, gas is generated and acts on the displaceable membrane to compress the first chamber and expel the active ingredient through the orifice for progressive delivery to the gastrointestinal tract.
Patent NZ-305169-A (NZ)
Title: Nitric oxide donors or inhibitors used to regulate cervical dilation and extensibility
Inventor: CHWALISZ KRISTOF
IPC: A61K31/565
Filed: 1996-03-14
Abstract: The invention describes the regulation of cervical dilatation and extensibility by the use of nitric oxide donors and/or substrates or nitric oxide inhibitors. There can be used either(a) at least one nitric oxide donor and/or substrate for manufacture of a medicament to be administered locally intracervically or intravaginally for induction of cervical ripening or(b) at least one nitric oxide inhibitor for manufacture of a medicament to be administered locally intracervically or intravaginally for treatment of cercvical insufficiency or preterm labor.
Patent NZ-332991-A (NZ)
Title: A bacterial or fungal abc transporter protein and its use in treating and diagnosing of infections of gram positive cocci
Inventor: BURNIE JAMES PETER
IPC: A61P31/04
Filed: 1997-07-07
Abstract: The present invention provides bacterial and fungal ABC transporter proteins, immunogenic fragments thereof, neutralising agents specific thereto and binding agents specific thereto for therapeutic and diagnostic use, together with diagnostic test methods, methods of same and kits for performing same. Also provided are immunodominant conserved antigens from gram positive staphylococci, together with neutralising and binding agents specific thereto for use in therapy and diagnosis, and methods of same. Also provided are Staphylococcal holomogues of IstA and IstB and immunogenic fragments thereof, and their uses in methods of treatment and diagnosis of the human or animal body.
Patent NZ-336675-A (NZ)
Title: Remineralizing material for organomineral tissues comprising a mixture of cationic and anionic ion-exchange resins
Inventor: MALMAGRO VALIENTE
IPC: A61K6/884
Filed: 1997-12-30
Abstract: An organomineral tissue remineralizing material comprises a mixture of cationic and anionic ion exchange resins, charged with the cations Ca2+ and Zn2+ and the anions F- and PO43- which correspond to the salts making up the organomineral tissue to be remineralised with the Ca2+, F- and PO43- ions in a molar ratio close to that corresponding to that tissue. The material is combined with other accessories components and sufficient quality of water, physiological serum or artificial saliva which give it the desired texture or pastiness.
Patent NZ-338077-A (NZ)
Title: On-site sewage treatment and disposal system
Inventor: HASSETT ALAN F
IPC: E03F1/00
Filed: 1998-03-19
Abstract: Provided is an on-site sewage treatment and disposal system, especially to below grade on-site leach fields for areas having a high ground water level.  The system includes a perimeter barrier arranged around a selected subterraneal volume. A drainage pipe, which is adapted to receive fluid, is provided and is at least partially located within the selected subterraneal volume inside the perimeter barrier.  A pump having a gas intake and a discharge side which discharges gas at a pressure greater than atmospheric pressure is also provided. The discharge side of the pump is in fluid communication with the selected subterraneal volume to lower the ground water level within the perimeter barrier to a level at or below the minimum depth below grade.  A method for on-site wastewater disposal is also provided utilizing the treatment and disposal system.
Patent NZ-503342-A (NZ)
Title: Apparatus for separating and repositioning dough pieces with first and second conveyors discharging pieces onto third conveyor
Inventor: FINKOWSKI JAMES W
IPC: A21C9/08
Filed: 1998-07-23
Abstract: An apparatus and a method for dough handling includes a first conveyor (14) for receiving dough and having a first discharge end (14A) for discharging dough. A second conveyor (16) receives dough and is positioned alongside the first conveyor (14) to convey in the direction of the first conveyor (16). The second conveyor has a second discharge end (16A) that is spaced-apart from the first discharge end (14A). The first and second conveyors (14, 16) can be used to separate dough pieces (21) from an elongated dough product (25) such as a roll and/or phase individual dough pieces (26) to provide them in succession for packaging or further processing.
Patent NZ-507400-A (NZ)
Title: Direct measurement of high molecular weight IGF-binding protein complexes with ELISA using an anti-IGFBP-3 capture antibody and detection by an antibody to ALS or IGF
Inventor: KHOSRAVI M
IPC: C12N1/20
Filed: 1999-03-08
Abstract: A method of assaying the growth hormone status of an individual by immuno-assay for the 150 KDa Insulin-like Growth Factor ternary complex (IGF/IGFBP-3/ALS) is described.  Alternatively, a binary complex may be assayed.  The method involves capturing the IGFBP complex with a first antibody coupled to a solid phase and detecting the complex with a second antibody coupled to a label.  A set of monoclonal and polyclonal antibodies useful for the assay is also provided.
Patent NZ-509086-A (NZ)
Title: Electrostatic layering process and coated units obtained thereby
Inventor: CORNELLI LIVIO MARIA
IPC: A61K47/32
Filed: 1999-05-21
Abstract: A process and apparatus for applying a layer to a pharmaceutical unit such as a seed or tablet is disclosed.  The steps comprises of: (a) coating the unit with particles of drug and/or excipient; the unit and the particles are at different electrical potentials such that electrostatic attraction occurs between them; (b) applying to the unit a binder comprising a solvent; (c) drying; and film -coating the unit with one or more polymeric members having controlled release, gastroresistance, targeted release or taste masking properties.
Patent NZ-511465-A (NZ)
Title: Controlled delivery of active agents
Inventor: BHATT PADMANABH
IPC: A61K9/52
Filed: 1999-10-26
Abstract: Controlled release of active agents from sustained release push delivery devices having high drug loading are described wherein residual drug content in the device is minimized by the utilization of a flow-promoting layer between the semi-permeable wall and the drug layer.
Patent NZ-512973-A (NZ)
Title: Methods for reducing mortality rates in poultry
Inventor: CARTER FRANKLIN A
IPC: A23K20/195
Filed: 2000-01-06
Abstract: Described is as method of reducing mortality in poultry by treating the poultry with an effective amount of natamycin. Also described is a method for reducing the incidence of the disease ascites in poultry by treating the poultry with an ascites-reducing amount of natamycin.
Patent NZ-514042-A (NZ)
Title: Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
Inventor: CUMMING JOHN GRAHAM
IPC: C07D473/34
Filed: 2000-03-17
Abstract: This invention concerns a bicyclic compound of Formula (I), wherein: G is N, CH or C(CN); ring X is a 5- or 6- membered fused heteroaryl ring which contains 1, 2, or 3 heteroatoms selected from oxygen, sulphur and nitrogen; m is 0 - 2; R1 is a group such as hydroxy, halo, trifluoromethyl, cyano, mercapto, nitro, amino, carboxy and carbamoyl; each of R2 and R3 is hydrogen, halo, C1-6alkyl, C2-6alkenyl or C2-6alkynyl; R4 is a group such as hydrogen, hydroxy, C1-6alkyl, C1-6alkoxy, amino and N-C1-6alkylamino; R5 is a group such as hydrogen, halo, trifluoromethyl, cyano, nitro, amino and hydroxy, and q is 0 - 4; or a pharmaceutically acceptable salt or an in vivo cleavable ester thereof; processes for its preparation and a pharmaceutical composition containing it.
Patent NZ-515163-A (NZ)
Title: Thiazolidinedione derivative and its use as antidiabetic
Inventor: BLACKLER PAUL DAVID JAMES
IPC: A61K31/00
Filed: 2000-04-19
Abstract: A polymorphic form of 5-[4-[2-(N- methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione,maleric acid salt (hereinafter referred to as the "Polymorph") characterized in that it: (i) provides an infra red spectrum containing peaks at 1360, 1326, 1241, 714 and 669 cm--1; and/or (ii) provides a Raman spectrum containing peaks at 1581, 768, 670, 271 and 226 cm-1; and/or (iii) provides a solid-state nuclear magnetic resonance spectrum containing peaks at chemical shifts substantially as set out in Table I; and/or (iv) provides an X-ray powder with diffraction (XRPD) pattern containing peaks substantially as set out in Table II; said polymorph being useful for treating diabetes mellitus and related disorders.
Patent NZ-516839-A (NZ)
Title: Oligonucleotides for inhibiting the expression of human mitotic kinesin related motor protein eg5
Inventor: UHLMANN EUGEN
IPC: A61K31/7088
Filed: 2000-07-21
Abstract: Described is an oligonucleotide or one of its derivatives characterised by a sequence that corresponds to a nucleotide sequence that encodes a defined part of human eg5 or a mutated form thereof. Further described is a method of producing said oligonucleotide and to its use.
Patent NZ-517957-A (NZ)
Title: Scalable data collection and computing apparatus
Inventor: GOOSSEN EMRAY RAY
IPC: G06F13/40
Filed: 2000-08-23
Abstract: A method and apparatus for collecting and distributing information to and from a computing element that is quickly scalable at the installation to varying types and numbers of signals. Standard sized modules (10) containing a generalized set of computation, discrete I/O, analog I/O, serial I/O, adaptable I/O, etc., or any combination thereof, provide the building blocks that can be attached to each other to provide the desired combination of functions. These modular components are mated to each other through a simple serial interface providing the inter-module communication interface and local power requirements. The modules are quickly stacked together and snapped in place in a manner supporting severe environmental conditions.
Patent NZ-521087-A (NZ)
Title: Method for the enzymatic resolution of the racemates of aminomethy-aryl-cyclohexanol derivatives
Inventor: BUSCHMANN HELMUT
IPC: C12P13/00
Filed: 2001-01-18
Abstract: A process for the enzymatic cleavage of the racemates of aminomethyl-aryl-cyclohexanol derivatives of formula (I) is disclosed, wherein the variables are as defined in the specification. Also disclosed are compounds of formula (II) which are suitable for the preparation of a medicament for treatment of pain, in particular migraine, acute pain and neuropathic or chronic pain, of inflammatory and allergic reactions, depressions, drug and/or alcohol abuse, gastritis, cardiovascular diseases, respiratory tract diseases, coughing, mental illness and/or epilepsy, and in particular of urinary incontinence, itching and/or diarrhoea.
Patent NZ-523332-A (NZ)
Title: Compositions comprising a boron compound and an amine oxide
Inventor: TSENG CHUEN-ING
IPC: B27K3/50
Filed: 2001-06-29
Abstract: A composition comprising an amine oxide and a boron compound for preserving and/or waterproofing a wood substrate by contacting the composition with the wood substrate is disclosed, wherein the boron compound may be boric acid, diboron tetrahydroxide, a borate, a boron oxide, a borane, or any combination thereof. Furthermore, a method for controlling plants, insects, or fungi or regulating the growth of plants comprising applying an insecticidal, herbicidal, fungicidal, or plant growth regulating effective amount of this composition to the plants, fungi, insects, the seeds of the plants, or the area on which the plants or fungi grow is also disclosed.
Patent NZ-529051-A (NZ)
Title: New polynucleotides and polypeptides of the IFNalpha-17 gene
Inventor: ESCARY JEAN-LOUIS
IPC: C12Q1/68
Filed: 2002-04-23
Abstract: Described are polynucleotides encoding IFN-alpha polypeptides. The polynucleotide sequences comprises at least one SNP selected from g771c and 808Ins(a) and the polypeptides can have the coding SNP G45R. Also described are isolated host cells, vectors, therapeutic agents useful for the treatment of cancers, infectious disease, autoimmune related diseases, cardiovascular diseases, metabolic disease, central nervous system diseases, wound healing, anemia and osteoporosis and methods of determining compounds having biological activity similar to G45R mutated IFNalpha-17 gene.
Patent NZ-530056-A (NZ)
Title: Single administration of 1.5 mg levonorgestrel increases compliance and decreases possibility of incorrect use of this post-coital contraceptive
Inventor: VAN LOOK PAUL F A
IPC: A61K31/565
Filed: 2002-11-26
Abstract: A dosage regimen for emergency contraception, pharmaceutical compositions of the same purpose, the use of levenorgestrel for the manufacture of pharmaceutical compositions for the same purpose, as well as to the manufacturing process of these pharmaceutical compositions are described. The emergency contraception carried out by the use of levonorgestrel as active ingredient is characterised by administering a single application dose containing 1.5 +/- 0.2 mg of levonorgestrel up to 72 hours after the coitus. These pharmaceutical compositions for emergency contraception contain only 1.5 +/- 0.2 mg of levonorgestrel as the active ingredient in each application dose in admixture with known excipients, diluents, flavouring or aromatizing, stabilizers, as well as formulation-promoting or formulation-providing additives, commonly used in the pharmaceutical practice.
Patent NZ-530780-A (NZ)
Title: Nucleic acid free ghost preparations
Inventor: LUBITZ WERNER
IPC: A61K39/00
Filed: 2002-07-11
Abstract: A preparation of bacterial ghosts which is substantially free of living bacterial cells, wherein the ratio of ghosts to living cells is at least 106:1; a pharmaceutical composition comprising the preparations; and a method for obtaining the preparation of bacterial ghosts.
Patent NZ-532546-A (NZ)
Title: Agricultural machine, particularly of the rotary mower type, comprising an improved chopping device
Inventor: NEUERBURG HORST
IPC: A01D34/66
Filed: 2002-10-01
Abstract: An agricultural machine equipped with a cutting device (4) is disclosed. The cutting device (4) includes a casing (9) and at least three cutting members (7) arranged above the casing (9) and connected to the casing such that they can rotate about a vertical axis (8). The cutting members (7) included cutting elements that describe circles (18) about the axis (8) of rotation of the respective cutting member (7), the circles (18) all being nearly of the same diameter. Transmission elements drive the rotation of the cutting members (7) about the respective axes (8). At least two adjacent cutting members (7b, 7c) have directions of rotation (10b, 10c) that are opposed and converge toward the front. The distance separating their axes (8b, 8c) is greater than at the distance separating the axes (8c, 8d) of two adjacent cutting members (7c, 7d) that have directions of rotation (10c, 10d) that do not converge toward the front.
Patent NZ-534617-A (NZ)
Title: Process for the production of strongly adherent coatings of photocurable compositions
Inventor: KUNZ MARTIN
IPC: B05D7/24
Filed: 2003-01-27
Abstract: A process and the corresponding apparatus for the production of strongly adherent coatings on an inorganic or organic substrate is disclosed, wherein in a first step: (a) a low-temperature plasma, a corona discharge or a flame is caused to act on the inorganic or organic substrate; in a second step: (b) one or more photoinitiators or mixtures of photoinitiators with monomers, containing at least one ethylenically unsaturated group, or solutions, suspensions or emulsions of the afore-mentioned substances, are applied at normal pressure to the inorganic or organic substrate; in a third step: (c) using suitable methods those afore-mentioned substances are dried and/or irradiated with electromagnetic waves; and, optionally, in a fourth step: (d) the substrate so pretreated is provided with a coating and the coating is cured or dried.